Intravenous infusion pump market to reach $8147.20M by 2030

According to a new report published by Allied Market Research, titled, “Intravenous Infusion Pump Market: Global Opportunity Analysis and Industry Forecast, 2021-2030” The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030. Intravenous infusion pump is a medical device used to infuse medications or nutrients into a patient’s circulatory system. These are commonly found in a medical setting as they are widely used in transferring medications in accurate dosages.

Infusion pumps such as ambulatory chemotherapy pumps, implantable pumps, and insulin pumps are useful for managing various diseases, such as cancer and diabetes, in home care settings. Furthermore, ambulatory infusion pumps are designed to be portable or wearable. In addition, infusion pumps are used to deliver fluids such as nutrients, medicines, and antibiotics in a patient’s body precisely and under a controlled environment. They are commonly used in hospitals, ambulatory surgery centers, home settings, infusion clinics, and long-term care facilities. In the last few years, the demand for home healthcare has increased significantly, owing to high prevalence of chronic diseases and rise in healthcare expenditure, majorly on hospitalization. Home healthcare provides patients with an affordable option compared to expensive hospital care, which, in turn, helps reduce the public expenditure on healthcare services. With the increasing need to reduce hospital stays, patients are increasingly adopting ambulatory infusion pumps that are cheaper than most other infusion pumps as well as easier to use. Thus, all these factors collectively boost the demand for infusion pump products, thereby augmenting the intravenous infusion pump market growth.

The global Intravenous infusion pump market is segmented into type, application, end user and region. By type, the market is categorized into volumetric infusion pumps, syringe infusion pumps, and patient-controlled analgesia infusion pumps. The applications covered in the study include oncology, parenteral nutrition, analgesia/pain management, and others. On the basis of end user, the market is segregated into hospitals & clinics, home healthcare, and others.

Key benefits:

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global intravenous infusion pump market to identify the prevailing opportunities.
• This study presents the competitive landscape of the global intravenous infusion pump market to predict the competitive environment across geographies.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Region- & country-wise analysis is provided to understand the intravenous infusion pump market trends and dynamics

Comprehensive competitive analysis and profiles of major market players such as F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU Medical, Inc., and Tandem Diabetes Care, Inc. Allied Market Research